Pulse Biosciences, Inc. (PLSE)
NASDAQ: PLSE · IEX Real-Time Price · USD
6.86
+0.01 (0.15%)
At close: Apr 23, 2024, 4:00 PM
7.00
+0.14 (2.04%)
Pre-market: Apr 24, 2024, 8:23 AM EDT
Pulse Biosciences Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for Pulse Biosciences.
Analyst Consensus: n/a
Analyst Ratings
There are currently no analyst ratings available for PLSE.
Recommendation Trends
| Rating | Apr '22 | May '22 | Jun '22 | Jul '22 | Aug '22 | Sep '22 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 0 | 0 | 0 | 0 | 0 |
| Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Hold | 0 | 1 | 1 | 1 | 1 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 0 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Sep 21, 2022 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | May 13, 2022 |
| Stephens & Co. | Stephens & Co. | Buy Maintains $14 → $12 | Buy | Maintains | $14 → $12 | +74.93% | Apr 1, 2022 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $20 → $8.5 | Strong Buy | Maintains | $20 → $8.5 | +23.91% | Apr 1, 2022 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $43 → $20 | Strong Buy | Maintains | $43 → $20 | +191.55% | Feb 10, 2022 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.92
from -0.88
EPS Next Year
n/a
from -0.92
Revenue Forecast
| Revenue | 2024 |
|---|---|
| High | n/a |
| Avg | n/a |
| Low | n/a |
Revenue Growth
| Revenue Growth | 2024 |
|---|---|
| High | - |
| Avg | - |
| Low | - |
EPS Forecast
| EPS | 2024 |
|---|---|
| High | -0.95 |
| Avg | -0.92 |
| Low | -0.88 |
EPS Growth
| EPS Growth | 2024 |
|---|---|
| High | - |
| Avg | - |
| Low | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.